↓ Skip to main content

Cochrane Database of Systematic Reviews

Drugs for treatment of very high blood pressure during pregnancy

Overview of attention for article published in Cochrane database of systematic reviews, July 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs
3 blogs
twitter
7 X users
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
206 Dimensions

Readers on

mendeley
596 Mendeley
citeulike
1 CiteULike
Title
Drugs for treatment of very high blood pressure during pregnancy
Published in
Cochrane database of systematic reviews, July 2013
DOI 10.1002/14651858.cd001449.pub3
Pubmed ID
Authors

Lelia Duley, Shireen Meher, Leanne Jones

Abstract

Very high blood pressure during pregnancy poses a serious threat to women and their babies. The aim of antihypertensive therapy is to lower blood pressure quickly but safety, to avoid complications. Antihypertensive drugs lower blood pressure but their comparative effectiveness and safety, and impact on other substantive outcomes is uncertain.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 596 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Spain 2 <1%
Tanzania, United Republic of 1 <1%
Brazil 1 <1%
South Africa 1 <1%
United Kingdom 1 <1%
Indonesia 1 <1%
New Zealand 1 <1%
Australia 1 <1%
Other 2 <1%
Unknown 583 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 83 14%
Student > Bachelor 74 12%
Researcher 53 9%
Student > Ph. D. Student 50 8%
Student > Postgraduate 42 7%
Other 113 19%
Unknown 181 30%
Readers by discipline Count As %
Medicine and Dentistry 220 37%
Nursing and Health Professions 50 8%
Pharmacology, Toxicology and Pharmaceutical Science 26 4%
Social Sciences 24 4%
Psychology 17 3%
Other 64 11%
Unknown 195 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2018.
All research outputs
#1,608,859
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#3,436
of 11,499 outputs
Outputs of similar age
#13,565
of 210,010 outputs
Outputs of similar age from Cochrane database of systematic reviews
#81
of 253 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,010 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 253 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.